Related Experiment Video

Updated: Jun 25, 2025

Development and Maintenance of a Preclinical Patient Derived Tumor Xenograft Model for the Investigation of Novel Anti-Cancer Therapies
09:29

Development and Maintenance of a Preclinical Patient Derived Tumor Xenograft Model for the Investigation of Novel Anti-Cancer Therapies

Published on: September 30, 2016

13.7K

Research Progress on CARM1 and its Relationship with Colorectal Cancer

Yuchen Wu1, Yannan Shen1

  • 1NHC Key Laboratory of Radiobiology, School of Public Health, Jilin University, Changchun, China.

Cancer Investigation
|May 30, 2024
PubMed

Insights

Coactivator-associated arginine methyltransferase 1 (CARM1) is a key target for colorectal cancer therapy. Research is advancing CARM1 inhibitors for effective cancer treatment and research, though challenges remain for in vivo applications.

Area of Science:

  • Biochemistry
  • Oncology
  • Pharmacology

Background:

  • Coactivator-associated arginine methyltransferase 1 (CARM1) is a significant enzyme in the PRMT family.
  • CARM1 plays a crucial role in regulating arginine methylation.
  • CARM1's association with colorectal cancer highlights its potential as a therapeutic target.

Purpose of the Study:

  • To review research progress on CARM1 and its connection to colorectal cancer.
  • To provide a theoretical foundation for colorectal cancer radiotherapy.
  • To discuss the development of CARM1 inhibitors as therapeutic agents and research tools.

Main Methods:

  • Literature review of CARM1 research.
  • Analysis of CARM1's role in colorectal cancer pathogenesis.
  • Summary of current CARM1 inhibitor development strategies.

Main Results:

  • CARM1 is implicated in colorectal cancer development and progression.
  • CARM1 inhibitors show promise as anti-cancer agents.
  • Challenges exist in developing selective, cell-permeable, and in vivo-active CARM1 inhibitors.

Conclusions:

  • CARM1 is a critical target for colorectal cancer therapy.
  • Further research is needed to overcome challenges in CARM1 inhibitor development.
  • CARM1 inhibitors may enhance the efficacy of colorectal cancer radiotherapy.
Keywords:
ADMACARM1MMAPRMTSDMAarginine methylation

More Related Videos

Discovery of Driver Genes in Colorectal HT29-derived Cancer Stem-Like Tumorspheres06:52

Discovery of Driver Genes in Colorectal HT29-derived Cancer Stem-Like Tumorspheres

Published on: July 22, 2020

6.5K
Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery06:46

Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery

Published on: September 27, 2024

250

Related Concept Videos

Tumor Progression02:07

Tumor Progression

Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
6.3K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
3.8K
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.5K